Winton Group LTD Organon & Co. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $250,099 - $374,566	-11,676 Reduced 17.87%	53,673 $1.26 Million
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $410,489 - $503,822	-17,610 Reduced 21.23%	65,349 $1.83 Million
Q3 2022 Nov 10, 2022	BUY	$23.4 - $34.25 $381,747 - $558,754	16,314 Added 24.48%	82,959 $1.94 Million
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $679,645 - $835,066	21,467 Added 47.52%	66,645 $2.25 Million
Q1 2022 May 11, 2022	BUY	$30.45 - $39.36 $659,212 - $852,104	21,649 Added 92.01%	45,178 $1.58 Million
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $674,576 - $873,631	23,529 New	23,529 $716,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.